Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niccolò Marchionni

Showing results (1-10 of 302) with videos related to

Pageof 31
Sort By:
European Journal of Internal Medicine|November 20, 2019
Practical use of Direct Oral Anti Coagulants (DOACs) in the older persons with atrial fibrillationMario Bo, Niccolò Marchionni
Giornale Italiano Di Cardiologia (2006)|July 20, 2007
[Psychological disorders and cardiovascular diseases]Matteo Monami, Niccolò Marchionni
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|July 5, 2016
Cholesterol: until which age 'the lower the better'?Niccolò Marchionni, Francesco Orso
Diabetes Research and Clinical Practice|May 23, 2008
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysisMatteo Monami, Niccolò Marchionni, Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|April 25, 2013
[Evidence-based versus evidence-biased medicine]Niccolò Marchionni, Francesco Orso, Antonio Cherubini
European Journal of Endocrinology|March 26, 2009
Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trialsMatteo Monami, Niccolò Marchionni, Edoardo Mannucci
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 11, 2019
Heart failure with mid-range ejection fraction: Current evidence and uncertaintiesRaffaele Martone, Niccolò Marchionni, Francesco Cappelli
Diabetes Research and Clinical Practice|September 9, 2008
Winners and losers at the rosiglitazone gamble A meta-analytical approach at the definition of the cardiovascular risk profile of rosiglitazoneMatteo Monami, Niccolò Marchionni, Edoardo Mannucci
Aging Clinical and Experimental Research|April 28, 2006
Calcium channel blockers and coronary heart diseaseMarco Inzitari, Mauro Di Bari, Niccolò Marchionni
European Heart Journal. Case Reports|October 8, 2021
Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case reportValentina Scheggi, Niccolò Marchionni, Pier Luigi Stefàno
Pageof 31

Showing results (1-10 of 302) with videos related to

Sort By:
Pageof 31
European Journal of Internal Medicine|November 20, 2019
Practical use of Direct Oral Anti Coagulants (DOACs) in the older persons with atrial fibrillationMario Bo, Niccolò Marchionni
Giornale Italiano Di Cardiologia (2006)|July 20, 2007
[Psychological disorders and cardiovascular diseases]Matteo Monami, Niccolò Marchionni
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|July 5, 2016
Cholesterol: until which age 'the lower the better'?Niccolò Marchionni, Francesco Orso
Diabetes Research and Clinical Practice|May 23, 2008
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysisMatteo Monami, Niccolò Marchionni, Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|April 25, 2013
[Evidence-based versus evidence-biased medicine]Niccolò Marchionni, Francesco Orso, Antonio Cherubini
European Journal of Endocrinology|March 26, 2009
Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trialsMatteo Monami, Niccolò Marchionni, Edoardo Mannucci
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 11, 2019
Heart failure with mid-range ejection fraction: Current evidence and uncertaintiesRaffaele Martone, Niccolò Marchionni, Francesco Cappelli
Diabetes Research and Clinical Practice|September 9, 2008
Winners and losers at the rosiglitazone gamble A meta-analytical approach at the definition of the cardiovascular risk profile of rosiglitazoneMatteo Monami, Niccolò Marchionni, Edoardo Mannucci
Aging Clinical and Experimental Research|April 28, 2006
Calcium channel blockers and coronary heart diseaseMarco Inzitari, Mauro Di Bari, Niccolò Marchionni
European Heart Journal. Case Reports|October 8, 2021
Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case reportValentina Scheggi, Niccolò Marchionni, Pier Luigi Stefàno
Pageof 31